Virpax Pharmaceuticals develops drug delivery and drug-releasing technologies for pain management and central nervous system disorders. Their preclinical candidates include a topical nonsteroidal anti-inflammatory drug for osteoarthritis, a liposomal gel for postoperative pain, and an intranasal spray for delivering labile peptide drugs into the brain. The company was founded in 2016 and is located in Berwyn, Pennsylvania.